Search results
Results from the WOW.Com Content Network
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [clarify], and other extracorporeal therapies for chronic and acute patients.
This page was last edited on 6 February 2024, at 23:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Hemodialysis, also spelled haemodialysis, or simply dialysis, is a process of filtering the blood of a person whose kidneys are not working normally. This type of dialysis achieves the extracorporeal removal of waste products such as creatinine and urea and free water from the blood when the kidneys are in a state of kidney failure.
(Reuters) -Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with ...
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [2] The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products.
In August 2008, Fresenius Kabi acquired 73.3% of Dabur Pharma of India. [12] In September 2008, Fresenius Kabi acquired APP Pharmaceuticals, Inc. [13] [non-primary source needed] In October 2011, the company agreed to acquire 51% of the share capital in Katholisches Klinikum Duisburg hospital. [14] [non-primary source needed]
For premium support please call: 800-290-4726 more ways to reach us
A liver support system or diachysis is a type of therapeutic device to assist in performing the functions of the liver. Such systems focus either on removing the accumulating toxins (liver dialysis), or providing additional replacement of the metabolic functions of the liver through the inclusion of hepatocytes to the device (bioartificial liver device).